Browse by author
Lookup NU author(s): Dr Tracey Willis, Dr Claire Wood, Dr Tuomo Polvikoski, Dr Rita Barresi, Professor Hanns Lochmuller, Emerita Professor Katherine Bushby, Professor Volker StraubORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Four and a half LIM protein 1 (FHL1/SLIM1) has recently been identified as the causative gene mutated in four distinct diseases affecting skeletal muscle that have overlapping features, including reducing body myopathy, X-linked myopathy, X-linked dominant scapuloperoneal myopathy and Emery-Dreifuss muscular dystrophy. FHL1 localises to the sarcomere and the sarcolemma and is believed to participate in muscle growth and differentiation as well as in sarcomere assembly. We describe in this case report a boy with a deletion of the entire FHL1 gene who is now 15 years of age and presented with muscle hypertrophy, reduced subcutaneous fat, rigid spine and short stature. This case is the first, to our knowledge, with a complete loss of the FHL1 protein and MAP7D3 in combination. It supports the theory that dominant negative effects (accumulation of cytotoxic-mutated FHL1 protein) worsen the pathogenesis. It extends the phenotype of FHL1-related myopathies and should prompt future testing in undiagnosed patients who present with unexplained muscle hypertrophy, contractures and rigid spine, particularly if male.
Author(s): Willis TA, Wood CL, Hudson J, Polvikoski T, Barresi R, Lochmüller H, Bushby K, Straub V
Publication type: Article
Publication status: Published
Journal: Clinical Genetics
Year: 2016
Volume: 90
Issue: 2
Pages: 166-170
Print publication date: 01/08/2016
Online publication date: 08/01/2016
Acceptance date: 12/11/2015
ISSN (print): 0009-9163
ISSN (electronic): 1399-0004
Publisher: Wiley-Blackwell
URL: http://dx.doi.org/10.1111/cge.12695
DOI: 10.1111/cge.12695
Altmetrics provided by Altmetric
